mWIG40/ PL9999999912
PL9999999912| 10/18/2024 5:09:45 PM | Chg. +61.7 | Open | High | Low | Previous Close |
|---|---|---|---|---|---|
| 6,156.2PLN | +1.01% | 6,119.7 | 6,169.1 | 6,105.4 | 6,094.5 |
GlobeNewswire
12/11/2023
Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire
12/7/2023
Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire
11/29/2023
Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
10/23/2023
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire
10/4/2023
Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire
9/13/2023
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
